Bausch + Lomb Corporation (BLCO)
Last updated: 2026-10-24 04:07:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Bausch + Lomb Corporation (BLCO) operates in the OPHTHALMIC GOODS sector and is listed on NYSE. The stock is currently priced at $17.47, with a market capitalization of $6.14B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $14.44 to $18.92. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$6.14B | |
$17.26 | |
$21.95 | |
$10.45 | |
$17.43 | |
353.30K | |
449.53K | |
-- | |
$18.92 | |
$14.44 | |
-- | |
-- |
Bausch + Lomb Corporation (BLCO) Latest Closing Stock Price
Bausch + Lomb Corporation (BLCO) last closed at $17.43 as of 2026-10-23 23:33:00, unchanged from the previous close of $17.43.
During the latest regular trading session, BLCO traded between $10.45 and $21.95, with a volume of 353.30K shares. The closing price was near the middle and near the upper end of its 52-week range.
Bausch + Lomb Corporation (BLCO) 7-Day Stock Price Change
Over the past seven days, Bausch + Lomb Corporation (BLCO) moved from $16.04 to $17.47, representing a gain of 8.93% ($1.43).
The stock traded between $15.70 and $17.48 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 505.95 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
BLCO 52-Week Price Position
Position in Range: 67.8%
BLCO is currently trading at $17.47, placing it 67.8% of the way from its 52-week low of $14.44 to its 52-week high of $18.92. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Bausch + Lomb Corporation (BLCO)?
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Bausch + Lomb Corporation Information
| Industry | OPHTHALMIC GOODS |
| Employees | 13000 |
| Exchange | NYSE |
| Company Website |
How to Buy Bausch + Lomb Corporation (BLCO) Stock on MEXC
Eligible investors can buy real shares of Bausch + Lomb Corporation (BLCO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Bausch + Lomb Corporation (BLCO) stock price today?
2.Is BLCO stock going up or down today?
3.What is BLCO pre-market price?
4.What is BLCO after-hours price?
5.Is BLCO stock trading now?
6.Where does BLCO sit relative to its 52-week high and low?
7.What sector is Bausch + Lomb Corporation in?
8.What is Bausch + Lomb Corporation's market capitalization and where is it listed?
9.How is BLCO valued in terms of P/E ratio and EPS?
10.Does Bausch + Lomb Corporation pay a dividend?
Explore More US Stocks
Search Stocks
BLCO Stock Calculator
Estimate the value between BLCO shares and USD.
BLCO Shares to USD
1.00 BLCO shares = 17.473 USD
Calculations are estimates based on the latest available price and are for reference only.


